Actor Patrick Stewart dies at 86; he lived with Alzheimer's and Lewy body dementia
Read more
Super Abril
super.abril.com.br

Actor Patrick Stewart dies at 86; he lived with Alzheimer's and Lewy body dementia

Actor Patrick Stewart, known for playing Professor Xavier in the X-Men franchise, passed away on Wednesday, October 28th, at the age of 86. Although family members have not disclosed the exact cause of death, it was revealed that the actor was simultaneously dealing with two neurodegenerative pathologies: Alzheimer's disease and Lewy body dementia.

Both are classified as some of the most prevalent neurodegenerative diseases and are characterized by cognitive deterioration, behavioral problems, and memory loss. However, despite the similarities, each condition has its distinct mechanisms and clinical manifestations.

Alzheimer's disease results from a defect in protein processing in the central nervous system. Abnormal and toxic proteins, notably beta-amyloids and tau, accumulate irregularly in the brain, both inside and outside neurons. This leads to the progressive death of neurons in areas crucial for memory and processing, such as the hippocampus and cortex, compromising cognition and causing changes in behavior. A common initial sign is forgetting recent events, and its origin is multifactorial, involving genetic and hereditary aspects.

Lewy body dementia, on the other hand, also involves protein accumulation, but in a different manner. In this condition, the alpha-synuclein protein deposits inside the neurons and in the cerebral cortex, forming aggregates called Lewy bodies. These deposits also serve as indicators of other illnesses, such as Parkinson's, and are named after the physician Frederic Lewy, who discovered the phenomenon. These deposits can affect various parts of the brain, interfering with communication and neuronal function, potentially leading to cell death in the long term, similar to what occurs in Alzheimer's.

Primary signs of Lewy body dementia include motor changes, such as tremors, muscle rigidity, and slowness, which often lead to confusion with Parkinson's, as happened with Robin Williams. The correct diagnosis was only established after his passing. Other recurring symptoms include sleep disorders, mental confusion, difficulty reasoning, and paranoia. The condition can also cause autonomic dysfunction, affecting involuntary bodily processes such as blood pressure regulation, digestion, and bladder control.

A distinctive symptom is the occurrence of visual hallucinations, which can affect up to 80% of patients. Although memory is affected over time, it is generally not the first symptom presented. While Alzheimer's tends to be more common in women, Lewy body dementia shows a higher incidence in men. Both diseases have no definitive cure, but treatments are available to manage symptoms and improve quality of life, including medications aimed at inhibiting neurotransmitter degradation or increasing cerebral dopamine.

Similar stories

NMC Royal Hospital Sharjah Implements Advanced Parkinson's Disease Treatment
Read more
www.khaleejtimes.com

NMC Royal Hospital Sharjah Implements Advanced Parkinson's Disease Treatment

NMC Royal Hospital Sharjah has introduced VYALEV®, a new advanced treatment option for individuals suffering from Parkinson's disease. This development marks a significant step in expanding specialized neurological care in Sharjah and the Northern Emirates.

Recently, this treatment was administered to a 58-year-old patient under the supervision of Dr. Ahmed Abida, a consultant neurologist at NMC Royal Hospital Sharjah. It helped manage symptoms that were becoming difficult to control despite taking multiple medications.

Parkinson's disease is a condition affecting the brain and nervous system that becomes increasingly difficult to manage over time. While many patients benefit from pills and other medications, some experience periods when the medication ceases to be effective between doses. This can lead to issues such as movement difficulties, muscle stiffness, walking problems, and reduced independence in daily life.

The patient treated at NMC Royal Hospital Sharjah had lived with Parkinson's disease for many years and had tried various drugs. Nevertheless, he continued to experience significant symptom fluctuations, which negatively affected his mobility and quality of life. A few days before hospitalization, he struggled with fatigue, pain, and walking problems related to muscle stiffness.

To ensure more stable symptom control, Dr. Abida recommended VYALEV®. This system delivers Parkinson's disease medication continuously via a small wearable pump. Unlike pills taken at different times throughout the day, this system provides a constant supply of the drug over 24 hours.

The patient spent three days in the hospital while the treatment was carefully tailored to his needs. During this time, the care team monitored his progress and provided training and support to both the patient and his family so they could confidently manage the treatment at home.

After completing the therapy, the patient noted improved symptom control, increased mobility, and reduced discomfort from stiffness. Furthermore, the therapy decreased the need for multiple daily doses of medication.

Charlotte Riondet, Senior Vice President of Operations at NMC Healthcare, commented on this achievement, stating: 'At NMC Royal Hospital Sharjah, we strive to make advanced healthcare more accessible to patients closer to home. The introduction of VYALEV® strengthens the specialized services available to people with neurological conditions and reflects our continuous investment in expert care, innovative treatments, and support for patients and their families.'

Dr. Rashid Shahbazi, Regional Medical Director for the Northern Emirates at NMC Healthcare, added: 'For people living with advanced Parkinson's disease, daily activities can become increasingly challenging when symptoms are no longer controlled by standard treatments. The introduction of this therapy expands opportunities for patients in the region and ensures they can receive specialized care from experienced multidisciplinary teams closer to their residences.'

For Dr. Abida, the successful treatment represents another important step in supporting individuals with severe Parkinson's disease. He noted: 'One of the biggest challenges for patients with advanced Parkinson's disease is the return of symptoms between medication doses. Continuous drug delivery can help ensure more stable symptom control for carefully selected patients. Our goal was to help this patient move more comfortably, maintain greater independence, and improve his overall quality of life. The hospital stay also allowed us to ensure that both the patient and his family felt comfortable and confident using the system before returning home.'

The implementation of VYALEV® at NMC Royal Hospital Sharjah underscores the importance of specialized care for Parkinson's disease and personalized treatment plans. Although this therapy is not suitable for everyone, it offers an additional treatment option for some patients whose symptoms are not adequately controlled by traditional methods.

Popular